Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Farley

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|February 10, 2004
Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedureJohn Farley, Catherine Uyehara, Glenn Hashiro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 24, 2011
Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C studyDenise L Jacobson, Paige Williams, Katherine Tassiopoulos, et al.
Obstetrics and Gynecology|January 30, 2002
Risk factors for early cytologic abnormalities after loop electrosurgical excision procedureCharles S Dietrich, Michael K Yancey, Kunio Miyazawa, et al.
American Journal of Public Health|September 1, 2005
Feasibility and outcome of HCV treatment in a Canadian federal prison populationJohn Farley, Shawn Vasdev, Benedikt Fischer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 23, 2008
Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected childrenKatherine Tassiopoulos, Paige L Williams, George R Seage, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219CJohn Farley, Philimon Gona, Marilyn Crain, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Ovarian cancer: markers of responseYoung-Jeong Na, John Farley, Audrey Zeh, et al.
Cancer|April 19, 2025
Gender equity gap persists, addressing the root cause through the lens of gynecologic oncology: An evidenced-based reviewJasmine Ebott, Kelsea R Grant, John Farley, et al.
Gynecologic Oncology|May 10, 2018
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)Panagiotis A Konstantinopoulos, William E Brady, John Farley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysisRosalind J Carter, Jeffrey Wiener, Elaine J Abrams, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|February 10, 2004
Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedureJohn Farley, Catherine Uyehara, Glenn Hashiro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 24, 2011
Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C studyDenise L Jacobson, Paige Williams, Katherine Tassiopoulos, et al.
Obstetrics and Gynecology|January 30, 2002
Risk factors for early cytologic abnormalities after loop electrosurgical excision procedureCharles S Dietrich, Michael K Yancey, Kunio Miyazawa, et al.
American Journal of Public Health|September 1, 2005
Feasibility and outcome of HCV treatment in a Canadian federal prison populationJohn Farley, Shawn Vasdev, Benedikt Fischer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 23, 2008
Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected childrenKatherine Tassiopoulos, Paige L Williams, George R Seage, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219CJohn Farley, Philimon Gona, Marilyn Crain, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Ovarian cancer: markers of responseYoung-Jeong Na, John Farley, Audrey Zeh, et al.
Cancer|April 19, 2025
Gender equity gap persists, addressing the root cause through the lens of gynecologic oncology: An evidenced-based reviewJasmine Ebott, Kelsea R Grant, John Farley, et al.
Gynecologic Oncology|May 10, 2018
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)Panagiotis A Konstantinopoulos, William E Brady, John Farley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysisRosalind J Carter, Jeffrey Wiener, Elaine J Abrams, et al.
Pageof 7